cabazitaxel,177lu-psma-617
novartis
['psma-617 ', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', '177lu,psma,617', 'lucab', 'cabazitaxel']
lucab: a phase i/ii trial evaluating cabazitaxel in combination with [177lu]lu-psma-617 in patients with #mcrpc. presented by . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology